Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Pharming Announces Positive Results of Study with Human Lactoferrin
Company will use positive results which indicate that rhLF can be consumed orally at high amounts with no adverse effect, for Generally Regarded as Safe (GRAS) registration of rhLF for nutritional applications.
- Pharming Announces Positive Results of Study with Human Lactoferrin
Company will use positive results which indicate that rhLF can be consumed orally at high amounts with no adverse effect, for Generally Regarded as Safe (GRAS) registration of rhLF for nutritional applications.
- Pharming Announces Positive Results of Study with Human Lactoferrin
Company will use positive results which indicate that rhLF can be consumed orally at high amounts with no adverse effect, for Generally Regarded as Safe (GRAS) registration of rhLF for nutritional applications.
- Pharming Announces Positive Results of Study with Human Lactoferrin
Company will use positive results which indicate that rhLF can be consumed orally at high amounts with no adverse effect, for Generally Regarded as Safe (GRAS) registration of rhLF for nutritional applications.
- Bone-Boosting Milk Protein Offers Future Hope for Osteoporosis Sufferers
Research by The University of Auckland’s Osteoporosis Research Group has found that a milk protein, lactoferrin, not only inhibits bone breakdown, but also boosts bone growth four times faster than normal when injected directly into bone.
- Bone-Boosting Milk Protein Offers Future Hope for Osteoporosis Sufferers
Research by The University of Auckland’s Osteoporosis Research Group has found that a milk protein, lactoferrin, not only inhibits bone breakdown, but also boosts bone growth four times faster than normal when injected directly into bone.
- Bone-Boosting Milk Protein Offers Future Hope for Osteoporosis Sufferers
Research by The University of Auckland’s Osteoporosis Research Group has found that a milk protein, lactoferrin, not only inhibits bone breakdown, but also boosts bone growth four times faster than normal when injected directly into bone.
- Bone-Boosting Milk Protein Offers Future Hope for Osteoporosis Sufferers
Research by The University of Auckland’s Osteoporosis Research Group has found that a milk protein, lactoferrin, not only inhibits bone breakdown, but also boosts bone growth four times faster than normal when injected directly into bone.
- Bone-Boosting Milk Protein Offers Future Hope for Osteoporosis Sufferers
Research by The University of Auckland’s Osteoporosis Research Group has found that a milk protein, lactoferrin, not only inhibits bone breakdown, but also boosts bone growth four times faster than normal when injected directly into bone.
- The American College for Advancement in Medicine - Commentary on the Meta-Analysis: High Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Not-for-profit medical society comments, notes flaws in study and study reporting.
- The American College for Advancement in Medicine - Commentary on the Meta-Analysis: High Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Not-for-profit medical society comments, notes flaws in study and study reporting.
- The American College for Advancement in Medicine - Commentary on the Meta-Analysis: High Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Not-for-profit medical society comments, notes flaws in study and study reporting.
- The American College for Advancement in Medicine - Commentary on the Meta-Analysis: High Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Not-for-profit medical society comments, notes flaws in study and study reporting.
- The American College for Advancement in Medicine - Commentary on the Meta-Analysis: High Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Not-for-profit medical society comments, notes flaws in study and study reporting.
- Improved Mood Connected to Anti-Inflammatory Properties of Tibetan PADMA Formula
performed at Austria's Innsbruck Medical University, examines earlier clinical research of PADMA's effects on intermittent claudication - study finds that participants reported feelings of increased well-being after taking PADMA and point to a possible mechanism that explains the previously reported mood changes in association with PADMA treatment.
- Improved Mood Connected to Anti-Inflammatory Properties of Tibetan PADMA Formula
performed at Austria's Innsbruck Medical University, examines earlier clinical research of PADMA's effects on intermittent claudication - study finds that participants reported feelings of increased well-being after taking PADMA and point to a possible mechanism that explains the previously reported mood changes in association with PADMA treatment.
- Improved Mood Connected to Anti-Inflammatory Properties of Tibetan PADMA Formula
performed at Austria's Innsbruck Medical University, examines earlier clinical research of PADMA's effects on intermittent claudication - study finds that participants reported feelings of increased well-being after taking PADMA and point to a possible mechanism that explains the previously reported mood changes in association with PADMA treatment.
- Improved Mood Connected to Anti-Inflammatory Properties of Tibetan PADMA Formula
performed at Austria's Innsbruck Medical University, examines earlier clinical research of PADMA's effects on intermittent claudication - study finds that participants reported feelings of increased well-being after taking PADMA and point to a possible mechanism that explains the previously reported mood changes in association with PADMA treatment.
- Improved Mood Connected to Anti-Inflammatory Properties of Tibetan PADMA Formula
performed at Austria's Innsbruck Medical University, examines earlier clinical research of PADMA's effects on intermittent claudication - study finds that participants reported feelings of increased well-being after taking PADMA and point to a possible mechanism that explains the previously reported mood changes in association with PADMA treatment.
- Improved Mood Connected to Anti-Inflammatory Properties of Tibetan PADMA Formula
performed at Austria's Innsbruck Medical University, examines earlier clinical research of PADMA's effects on intermittent claudication - study finds that participants reported feelings of increased well-being after taking PADMA and point to a possible mechanism that explains the previously reported mood changes in association with PADMA treatment.
- Small Study Shows SAMe May Improve Treatment of Depression
Researchers at Massachusetts General Hospital have found that adding SAMe to a standard antidepressant may be helpful to patients who have not responded to single-drug treatment for clinical depression.
- Small Study Shows SAMe May Improve Treatment of Depression
Researchers at Massachusetts General Hospital have found that adding SAMe to a standard antidepressant may be helpful to patients who have not responded to single-drug treatment for clinical depression.
- Small Study Shows SAMe May Improve Treatment of Depression
Researchers at Massachusetts General Hospital have found that adding SAMe to a standard antidepressant may be helpful to patients who have not responded to single-drug treatment for clinical depression.
- Small Study Shows SAMe May Improve Treatment of Depression
Researchers at Massachusetts General Hospital have found that adding SAMe to a standard antidepressant may be helpful to patients who have not responded to single-drug treatment for clinical depression.
- Small Study Shows SAMe May Improve Treatment of Depression
Researchers at Massachusetts General Hospital have found that adding SAMe to a standard antidepressant may be helpful to patients who have not responded to single-drug treatment for clinical depression.
- Initial Results Reported in Clinical Study of Herbal Product Honso® Sho-saiko-to (H09)
Japanese herbal product, Sho-saiko-to (H09), is under a clinical phase II trial by Memorial Sloan-Kettering Cancer Center to determine its effect on hepatitis C patients; preliminary results reported.
- Initial Results Reported in Clinical Study of Herbal Product Honso® Sho-saiko-to (H09)
Japanese herbal product, Sho-saiko-to (H09), is under a clinical phase II trial by Memorial Sloan-Kettering Cancer Center to determine its effect on hepatitis C patients; preliminary results reported.
- Initial Results Reported in Clinical Study of Herbal Product Honso® Sho-saiko-to (H09)
Japanese herbal product, Sho-saiko-to (H09), is under a clinical phase II trial by Memorial Sloan-Kettering Cancer Center to determine its effect on hepatitis C patients; preliminary results reported.
- Initial Results Reported in Clinical Study of Herbal Product Honso® Sho-saiko-to (H09)
Japanese herbal product, Sho-saiko-to (H09), is under a clinical phase II trial by Memorial Sloan-Kettering Cancer Center to determine its effect on hepatitis C patients; preliminary results reported.
- VERIS Research: Monthly Research Update On Antioxidants, Botanicals, and Other Nutrients.
Phytosterols Continue to Show Promise in Reducing Cholesterol Levels; Vitamin E Supplements May Reduce Patients' Tendency Toward Blood Clots; Vitamins E and C Block Gene Involved in Prostate Cancer in a Cell Study; Beta-Carotene May Help Prevent Allergies; Mouse Study Suggests that Alpha-Lipoic Acid May Be Beneficial in Asthma; St. John's Wort May Help Patients with Difficult-to-Diagnose Psychological Disorders;
- VERIS Research: Monthly Research Update On Antioxidants, Botanicals, and Other Nutrients.
Phytosterols Continue to Show Promise in Reducing Cholesterol Levels; Vitamin E Supplements May Reduce Patients' Tendency Toward Blood Clots; Vitamins E and C Block Gene Involved in Prostate Cancer in a Cell Study; Beta-Carotene May Help Prevent Allergies; Mouse Study Suggests that Alpha-Lipoic Acid May Be Beneficial in Asthma; St. John's Wort May Help Patients with Difficult-to-Diagnose Psychological Disorders;
- VERIS Research: Monthly Research Update On Antioxidants, Botanicals, and Other Nutrients.
Phytosterols Continue to Show Promise in Reducing Cholesterol Levels; Vitamin E Supplements May Reduce Patients' Tendency Toward Blood Clots; Vitamins E and C Block Gene Involved in Prostate Cancer in a Cell Study; Beta-Carotene May Help Prevent Allergies; Mouse Study Suggests that Alpha-Lipoic Acid May Be Beneficial in Asthma; St. John's Wort May Help Patients with Difficult-to-Diagnose Psychological Disorders;
- VERIS Research: Monthly Research Update On Antioxidants, Botanicals, and Other Nutrients.
Phytosterols Continue to Show Promise in Reducing Cholesterol Levels; Vitamin E Supplements May Reduce Patients' Tendency Toward Blood Clots; Vitamins E and C Block Gene Involved in Prostate Cancer in a Cell Study; Beta-Carotene May Help Prevent Allergies; Mouse Study Suggests that Alpha-Lipoic Acid May Be Beneficial in Asthma; St. John's Wort May Help Patients with Difficult-to-Diagnose Psychological Disorders;
- VERIS Research: Monthly Research Update On Antioxidants, Botanicals, and Other Nutrients.
Phytosterols Continue to Show Promise in Reducing Cholesterol Levels; Vitamin E Supplements May Reduce Patients' Tendency Toward Blood Clots; Vitamins E and C Block Gene Involved in Prostate Cancer in a Cell Study; Beta-Carotene May Help Prevent Allergies; Mouse Study Suggests that Alpha-Lipoic Acid May Be Beneficial in Asthma; St. John's Wort May Help Patients with Difficult-to-Diagnose Psychological Disorders;
- VERIS Research: Monthly Research Update On Antioxidants, Botanicals, and Other Nutrients.
Phytosterols Continue to Show Promise in Reducing Cholesterol Levels; Vitamin E Supplements May Reduce Patients' Tendency Toward Blood Clots; Vitamins E and C Block Gene Involved in Prostate Cancer in a Cell Study; Beta-Carotene May Help Prevent Allergies; Mouse Study Suggests that Alpha-Lipoic Acid May Be Beneficial in Asthma; St. John's Wort May Help Patients with Difficult-to-Diagnose Psychological Disorders;
- Vitamin E May Offer Protection Against the Risk of Developing ALS
Researchers from the Harvard School of Public Health and the American Cancer Society have found that vitamin E may play an important role in the prevention of the devastating motor neuron disease ALS (amyotrophic lateral sclerosis).
- Vitamin E May Offer Protection Against the Risk of Developing ALS
Researchers from the Harvard School of Public Health and the American Cancer Society have found that vitamin E may play an important role in the prevention of the devastating motor neuron disease ALS (amyotrophic lateral sclerosis).
- Vitamin E May Offer Protection Against the Risk of Developing ALS
Researchers from the Harvard School of Public Health and the American Cancer Society have found that vitamin E may play an important role in the prevention of the devastating motor neuron disease ALS (amyotrophic lateral sclerosis).
- Vitamin E May Offer Protection Against the Risk of Developing ALS
Researchers from the Harvard School of Public Health and the American Cancer Society have found that vitamin E may play an important role in the prevention of the devastating motor neuron disease ALS (amyotrophic lateral sclerosis).
- Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer
Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000.
- Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer
Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000.
- Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer
Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000.
- Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer
Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000.
- Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer
Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000.
- Omega-3 Fats Feed the Human Brain, Not the Hips
Research reported in December PUFA Newsletter suggests that ocosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) feed the human brain and may improve psychiatric conditions as well as visual function.
- Omega-3 Fats Feed the Human Brain, Not the Hips
Research reported in December PUFA Newsletter suggests that ocosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) feed the human brain and may improve psychiatric conditions as well as visual function.
- Omega-3 Fats Feed the Human Brain, Not the Hips
Research reported in December PUFA Newsletter suggests that ocosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) feed the human brain and may improve psychiatric conditions as well as visual function.
- Omega-3 Fats Feed the Human Brain, Not the Hips
Research reported in December PUFA Newsletter suggests that ocosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) feed the human brain and may improve psychiatric conditions as well as visual function.
- Omega-3 Fats Feed the Human Brain, Not the Hips
Research reported in December PUFA Newsletter suggests that ocosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) feed the human brain and may improve psychiatric conditions as well as visual function.
- Study Examines Relationship of Vitamin A Pathway to Breast Tumor Progression
Study suggests that defects in vitamin A bioactivity may be a possible contributor to human carcinogenesis since vitamin A is required for activation of the retinoic acid receptor (RAR), which induces differentiation of adult epithelial cells.
- Study Examines Relationship of Vitamin A Pathway to Breast Tumor Progression
Study suggests that defects in vitamin A bioactivity may be a possible contributor to human carcinogenesis since vitamin A is required for activation of the retinoic acid receptor (RAR), which induces differentiation of adult epithelial cells.
- Study Examines Relationship of Vitamin A Pathway to Breast Tumor Progression
Study suggests that defects in vitamin A bioactivity may be a possible contributor to human carcinogenesis since vitamin A is required for activation of the retinoic acid receptor (RAR), which induces differentiation of adult epithelial cells.
- Study Examines Relationship of Vitamin A Pathway to Breast Tumor Progression
Study suggests that defects in vitamin A bioactivity may be a possible contributor to human carcinogenesis since vitamin A is required for activation of the retinoic acid receptor (RAR), which induces differentiation of adult epithelial cells.
- Lycopene Supplements Found to Reduce Cancer-Causing Cell Count
Study published in the Fall issue of Journal of Medicinal Food demonstrated that lycopene supplements decreased the proliferation of cancer cells at certain intervals of the study.
- Lycopene Supplements Found to Reduce Cancer-Causing Cell Count
Study published in the Fall issue of Journal of Medicinal Food demonstrated that lycopene supplements decreased the proliferation of cancer cells at certain intervals of the study.
- Lycopene Supplements Found to Reduce Cancer-Causing Cell Count
Study published in the Fall issue of Journal of Medicinal Food demonstrated that lycopene supplements decreased the proliferation of cancer cells at certain intervals of the study.
- Lycopene Supplements Found to Reduce Cancer-Causing Cell Count
Study published in the Fall issue of Journal of Medicinal Food demonstrated that lycopene supplements decreased the proliferation of cancer cells at certain intervals of the study.
- Lycopene Supplements Found to Reduce Cancer-Causing Cell Count
Study published in the Fall issue of Journal of Medicinal Food demonstrated that lycopene supplements decreased the proliferation of cancer cells at certain intervals of the study.
- Lycopene Supplements Found to Reduce Cancer-Causing Cell Count
Study published in the Fall issue of Journal of Medicinal Food demonstrated that lycopene supplements decreased the proliferation of cancer cells at certain intervals of the study.
- Lycopene Supplements Found to Reduce Cancer-Causing Cell Count
Study published in the Fall issue of Journal of Medicinal Food demonstrated that lycopene supplements decreased the proliferation of cancer cells at certain intervals of the study.
- Study Concludes DHA Restores Blood Vessel Function in Children With High Cholesterol
Study published in the December issue of The International Journal of Clinical Pharmacology and Therapeutics concludes that DHA restores normal blood vessel function in children with inherited high cholesterol.
- Study Concludes DHA Restores Blood Vessel Function in Children With High Cholesterol
Study published in the December issue of The International Journal of Clinical Pharmacology and Therapeutics concludes that DHA restores normal blood vessel function in children with inherited high cholesterol.
- Study Concludes DHA Restores Blood Vessel Function in Children With High Cholesterol
Study published in the December issue of The International Journal of Clinical Pharmacology and Therapeutics concludes that DHA restores normal blood vessel function in children with inherited high cholesterol.
- Study Concludes DHA Restores Blood Vessel Function in Children With High Cholesterol
Study published in the December issue of The International Journal of Clinical Pharmacology and Therapeutics concludes that DHA restores normal blood vessel function in children with inherited high cholesterol.
- Study Concludes DHA Restores Blood Vessel Function in Children With High Cholesterol
Study published in the December issue of The International Journal of Clinical Pharmacology and Therapeutics concludes that DHA restores normal blood vessel function in children with inherited high cholesterol.
- New Study Shows Benefits for Autism and Asperger’s Syndrome With Essential Fatty Acid Supplementation
Pilot trial, published in January/February 2005 issue of Autism-Asperger’s Digest, shows beneficial effects of essential fatty acids (EFAs) on language and learning skills in children with autism and Asperger’s syndrome.
- New Study Shows Benefits for Autism and Asperger’s Syndrome With Essential Fatty Acid Supplementation
Pilot trial, published in January/February 2005 issue of Autism-Asperger’s Digest, shows beneficial effects of essential fatty acids (EFAs) on language and learning skills in children with autism and Asperger’s syndrome.
- New Study Shows Benefits for Autism and Asperger’s Syndrome With Essential Fatty Acid Supplementation
Pilot trial, published in January/February 2005 issue of Autism-Asperger’s Digest, shows beneficial effects of essential fatty acids (EFAs) on language and learning skills in children with autism and Asperger’s syndrome.
- New Study Shows Benefits for Autism and Asperger’s Syndrome With Essential Fatty Acid Supplementation
Pilot trial, published in January/February 2005 issue of Autism-Asperger’s Digest, shows beneficial effects of essential fatty acids (EFAs) on language and learning skills in children with autism and Asperger’s syndrome.
- New Study Shows Benefits for Autism and Asperger’s Syndrome With Essential Fatty Acid Supplementation
Pilot trial, published in January/February 2005 issue of Autism-Asperger’s Digest, shows beneficial effects of essential fatty acids (EFAs) on language and learning skills in children with autism and Asperger’s syndrome.
- Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market
Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market.
- Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market
Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market.
- Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market
Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market.
- Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market
Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market.
- Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market
Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market.
- Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market
Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market.
- Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market
Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market.
- Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market
Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market.
- Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market
Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market.
- Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market
Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market.
- Fluxome and GlycaNova Join Forces to Bring a Promising Beta Glucan Product to the US Dietary Supplement Market
Nutraceutical ingredient provider Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market.
- AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.)
The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.)
- AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.)
The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.)
- AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.)
The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.)
- AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.)
The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.)
- AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.)
The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.)
- AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.)
The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.)
- AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.)
The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.)
- AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.)
The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.)
- AHP Releases Monograph Standards on Stinging Nettle Root (Urtica dioica L.)
The American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization, has released its quality control standards and therapeutic compendium for the popular botanical dietary supplement Stinging Nettle Root (Urtica dioica L.)
- Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West
Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif.
- Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West
Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif.
- Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West
Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif.
- Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West
Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif.
- Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West
Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif.
- Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West
Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif.
- Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West
Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif.
- Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West
Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif.
- Rudi's Organic Bakery Unveils New Brand and Packaging at Natural Products Expo West
Rudi's Organic Bakery, Inc. has unveiled its new brand identity and packaging at the annual Natural Products Expo West in Anaheim, Calif.
- Senators reach agreement on dietary supplement legislation
Several weeks ago, Senators McCain and Dorgan introduced S. 3002, the Dietary Supplement Safety Act of 2010, stirring up vocal industry reaction at what it felt was 'over the top' regulation. Last week, Senator McCain withdrew support for his own bill.
- Senators reach agreement on dietary supplement legislation
Several weeks ago, Senators McCain and Dorgan introduced S. 3002, the Dietary Supplement Safety Act of 2010, stirring up vocal industry reaction at what it felt was 'over the top' regulation. Last week, Senator McCain withdrew support for his own bill.
- Senators reach agreement on dietary supplement legislation
Several weeks ago, Senators McCain and Dorgan introduced S. 3002, the Dietary Supplement Safety Act of 2010, stirring up vocal industry reaction at what it felt was 'over the top' regulation. Last week, Senator McCain withdrew support for his own bill.
- Senators reach agreement on dietary supplement legislation
Several weeks ago, Senators McCain and Dorgan introduced S. 3002, the Dietary Supplement Safety Act of 2010, stirring up vocal industry reaction at what it felt was 'over the top' regulation. Last week, Senator McCain withdrew support for his own bill.
- Senators reach agreement on dietary supplement legislation
Several weeks ago, Senators McCain and Dorgan introduced S. 3002, the Dietary Supplement Safety Act of 2010, stirring up vocal industry reaction at what it felt was 'over the top' regulation. Last week, Senator McCain withdrew support for his own bill.
- Senators reach agreement on dietary supplement legislation
Several weeks ago, Senators McCain and Dorgan introduced S. 3002, the Dietary Supplement Safety Act of 2010, stirring up vocal industry reaction at what it felt was 'over the top' regulation. Last week, Senator McCain withdrew support for his own bill.
|
Findings Indicate a Synergistic Effect of Sea Plant Minerals and scFOS®
GOLDEN, December 13, 2004, Colorado – GTC Nutrition, a business unit of Corn Products International, Inc. (NYSE: CPO), today released the findings of a recent study conducted on CalciLife™ prebiotic mineral formulation, that indicates CalciLife increases absorption and retention of calcium as well as increasing bone mineral density.
The study, conducted by the School of Human Ecology at Louisiana State University, evaluated the effects of CalciLife on mineral absorption and retention, bone mineral content and bone mineral density in an animal population. CalciLife™ prebiotic mineral formulation is a combination of Aquamin F™, a sea plant derived mineral source rich in calcium and magnesium, and NutraFlora® scFOS®, a prebiotic fiber that enhances calcium absorption and retention.
Results of the 12-week study reveal that laboratory rats fed CalciLife as part of a standardized diet during a 10-week phase of the study showed a statistically significantly higher level of calcium absorption and retention as compared to a control group. Furthermore, the animals fed CalciLife had a statistically significant higher level of vertebral bone mineral density as compared to the control group.
Current estimates1 show that typical calcium consumption by an average postmenopausal woman falls below the recommended level of 1200 mg per day. Compounding this problem is the fact that some women typically limit their intake of high calcium foods, such as whole milk and cheese, for weight control considerations. Enriching one’s diet with calcium-fortified foods can address this problem and using CalciLife will provide the added benefit of including a prebiotic fiber, which helps to enhance maximum calcium absorption.
(more)
CalciLife™ prebiotic mineral formulation, which can be incorporated into numerous applications from baked goods, bars and beverages, to confectionary, dairy and dietary supplements, is just one product
in GTC Nutrition’s innovative product line. Other products in the portfolio include Aquamin™ natural sea plant derivative, NutraFlora® prebiotic dietary fiber, Natureal™ oat bran concentrate and Xylitol natural polyol.
About GTC Nutrition
GTC Nutrition, a business unit of Corn Products International, Inc., is a recognized leader in providing science-based ingredients to the food processing, dietary supplement and animal feed industries. GTC Nutrition promotes health throughout North America, South America, Mexico, Australia and New Zealand with innovative functional food ingredients and unsurpassed customer support. For more information, visit www.gtcnutrition.com.
# # #
1 Bryant RJ, Cadogan J, Weaver CM., The New Dietary Reference Intakes for Calcium:
Implications for Osteoporosis. J AM Coll Nutr 1999; 18:406S-412S.
|